See the latest news and media coverage for Veeva. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
In short: Veeva posted strong Q2 fiscal 2027 results, won global Vault CRM deals, and advanced its AI strategy with Falcon.
The partnership expands to include CTMS, eTMF, Study Startup, and Site Connect. IQVIA will deploy these tools across clinical development studies to enhance efficiency and site centricity.
Servier uses Veeva OpenData across 80 countries to create a unified data foundation. This strategy addresses common AI implementation barriers and enables consistent commercial execution.
The application, part of Veeva Quality Cloud, provides real-time insights and streamlined workflows for environmental, health, and safety compliance.
Total revenues were $882.9M, up 16% YoY, and subscription revenues grew 15% to $730.2M. The company also raised its fiscal 2027 guidance.
Veeva Systems topped October 23 trading volume at $440M, driven by upgraded 2027 EPS guidance to $9.21 and $3.68B-$3.69B revenue targets.
Veeva Systems (NYSE:VEEV) said IQVIA will adopt Veeva's core clinical applications as enterprise standards across all IQVIA studies. The expanded agreement covers Veeva Clinical Trial...
Veeva Systems shares closed at $270.53, up 3.69% on the New York stock exchange on September 23. This comes as another top-20 biopharmaceutical company adopts its flagship Bolt CRM platform and partners with Amgen...
Veeva Systems (NYSE:VEEV) is positioning artificial intelligence as an incremental growth opportunity beyond its previously stated goal of reaching $6 billion in revenue by 2030...
Track Veeva and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Veeva and other trending companies.
